使い捨てバイオプロセシングシステムの世界市場：2017年〜2021年

バイオ医薬品の製造に特化した使い捨てバイオプロセシング機器およびその付属品に利用されるバイオプロセシング技術は、急速に発展しています。これらのシステムの目的は、スチール製のバイオリアクター装置とその付属品の殺菌、洗浄、保守などに関連するコストを低減することにあります。世界の使い捨てバイオプロセシングシステム市場は、2017年から2021年の期間、7.83%のCAGRで拡大する見込みです。

当レポートでは、使い捨てバイオプロセシングシステムの世界市場について調査し、市場の基本構造や、市場成長への主な影響要因、市場動向と市場規模の予測、用途・製品タイプ・エンドユーザー・地域別の詳細な動向、市場発展の方向性を分析するほか、競合情勢、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査手法

第4章 イントロダクション

• 市場のハイライト

第5章 市場情勢

• 市場概要
• 市場規模と予測
• ファイブフォース分析

第6章 市場区分：用途別

• 市場概要
• モノクローナル抗体(mAb）
• ワクチン生産
• 植物細胞培養
• 末梢血管細胞移植(PSCT)
• その他

第7章 市場区分：製品タイプ別

• 市場概要
• バッグ、ミキサー
• バイオリアクター、発酵槽
• ろ過装置、サンプリング装置
• バイオプロセスコンテナ
• 配管システム(コネクター/パイプ)
• その他

第8章 市場区分：エンドユーザー

• 市場概要
• 製薬企業
• 受託臨床試験実施機関(CTO)、受託医薬品製造機関(CMO)
• バイオテクノロジー企業
• 学術研究機関

第9章 地域区分

• 市場概要
• 南北アメリカ
• 欧州・中東・アフリカ
• アジア太平洋

第10章 意思決定の枠組み

第11章 市場促進要因と課題

• 市場促進要因
• 市場促進要因の影響力
• 市場の課題
• 市場の課題の影響力

第12章 市場動向

• ダウンストリームディスポーザブルの登場
• バイオプロセシングシステムの継続的な発展を促すシングルユーステクノロジー(SUT)

第13章 ベンダー概要

• 競合シナリオ

第14章 主要ベンダーの分析

• Danaher
• GE Healthcare
• Merck
• Sartorius
• Thermo Fisher Scientific
• その他の主要なベンダー

第15章 付録

• Exhibit 01: Advantages of single-use technologies over stainless steel technology
• Exhibit 02: Global single-use bioprocessing systems market ($ billions)
• Exhibit 03: Ongoing trends in biopharmaceutical industry impacting the adoption of single-use technologies
• Exhibit 04: Five forces analysis
• Exhibit 05: Global single-use bioprocessing systems market by application 2016-2021 (%)
• Exhibit 06: Global single-use bioprocessing systems market for mAB production 2016-2021 ($ millions)
• Exhibit 07: Global single-use bioprocessing systems market for vaccine production 2016-2021 ($ millions)
• Exhibit 08: Global single-use bioprocessing systems market for plant cell cultivation 2016-2021 ($ millions)
• Exhibit 09: Global single-use bioprocessing systems market for PSCTs 2016-2021 ($ millions)
• Exhibit 10: Global single-use bioprocessing systems market for other applications 2016-2021 ($ millions)
• Exhibit 11: Global single-use bioprocessing systems market by product type 2016-2021 (%)
• Exhibit 12: Global single-use bags and mixers market 2016-2021 ($ millions)
• Exhibit 13: Global SUBs and fermenters market 2016-2021 ($ millions)
• Exhibit 14: Global single-use filtration devices and sampling systems market 2016-2021 ($ millions)
• Exhibit 15: Global single-use bioprocess containers market 2016-2021 ($ millions)
• Exhibit 16: Global single-use tubing systems market 2016-2021 ($ millions)
• Exhibit 17: Global single-use others market 2016-2021 ($ millions)
• Exhibit 18: Global single-use bioprocessing systems market by end-users 2016 and 2021
• Exhibit 19: Pharmaceutical companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
• Exhibit 20: CROs and CMOs in global single-use bioprocessing systems market 2016-2021 ($ millions)
• Exhibit 21: Biotech companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
• Exhibit 22: Academic and research institutions in global single-use bioprocessing systems market 2016-2021 ($ millions)
• Exhibit 23: Global single-use bioprocessing systems market by geography 2016-2021
• Exhibit 24: Single-use bioprocessing systems market in Americas 2016-2021 ($ billions)
• Exhibit 25: Single-use bioprocessing systems market in EMEA 2016-2021 ($ billions)
• Exhibit 26: Single-use bioprocessing systems market in APAC 2016-2021 ($ billions)
• Exhibit 27: Recent M&As in the single-use bioprocessing systems market
• Exhibit 28: Impact of drivers
• Exhibit 29: Impact of challenges
• Exhibit 30: Advantages of implementing single-use bioprocessing systems
• Exhibit 31: Strategic success factor of consideration for companies
• Exhibit 32: Danaher: Profile
• Exhibit 33: Danaher: Strength analysis
• Exhibit 34: Danaher: Strategy assessment
• Exhibit 35: Danaher: Opportunity assessment
• Exhibit 36: GE Healthcare: Profile
• Exhibit 37: GE Healthcare: Strength analysis
• Exhibit 38: GE Healthcare: Strategy assessment
• Exhibit 39: GE Healthcare: Opportunity assessment
• Exhibit 40: Merck: Profile
• Exhibit 41: Merck: Strength analysis
• Exhibit 42: Merck: Strategy assessment
• Exhibit 43: Merck: Opportunity assessment
• Exhibit 44: Sartorius: Profile
• Exhibit 45: Sartorius: Strength analysis
• Exhibit 46: Sartorius: Strategy assessment
• Exhibit 47: Sartorius: Opportunity assessment
• Exhibit 48: Thermo Fisher Scientific: Profile
• Exhibit 49: Thermo Fisher Scientific: Strength analysis
• Exhibit 50: Thermo Fisher Scientific: Strategy assessment
• Exhibit 51: Thermo Fisher Scientific: Opportunity assessment

About Single-Use Bioprocessing System

The single-use bioprocessing systems market is rapidly evolving. It focuses on developing disposable bioprocessing equipment and accessories for manufacturing of biopharmaceutical products. Bioprocess is a technique that produces biological materials such as a genetically engineered microbial strain for commercial use. For example, commercially useful chemicals are produced through bioprocess techniques such as microbial fermentation or degradation. The traditional approaches in bioprocessing involve stainless steel equipment that are not just difficult to maintain but also time-consuming and costly.

Technavio's analysts forecast the global single-use bioprocessing system market to grow at a CAGR of 7.83% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global single-use bioprocessing system market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of key vendors to end-users such as pharmaceutical companies, CROs/CMOs, biotech companies, and academic and research institutions.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

Technavio's report, Global Single-Use Bioprocessing System Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• Danaher
• GE Healthcare
• Merck
• Sartorius
• Thermo Fisher Scientific

Other Prominent Vendors

• Broadley-James Corporation
• Eppendorf
• Saint-Gobain

Market driver

• Single-use technology (SUT) combats global drug shortage problem.
• For a full, detailed list, view our report

Market challenge

• Risk of leachables and extractables from plastics used in disposable systems.
• For a full, detailed list, view our report

Market trend

• Increasing adoption of single-use bioprocessing in pre-clinical and commercial stages.
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

• Key market highlights

PART 05: Market landscape

• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by application

• Market overview
• mAB production
• Vaccine production
• Plant cell cultivation
• PSCTs
• Others

PART 07: Market segmentation by product type

• Market overview
• Bags and mixers
• Bioreactors and fermenters
• Filtration devices and sampling systems
• Bioprocess containers
• Tubing systems (connectors/pipes)
• Others

PART 08: Market segmentation by end-users

• Market overview
• Pharmaceutical companies
• CROs & CMOs
• Biotechnology companies
• Academic and research institutions

PART 09: Geographical segmentation

• Market overview
• Americas
• EMEA
• APAC

PART 10: Decision framework

PART 11: Drivers and challenges

• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends

• Increasing adoption of single-use bioprocessing in pre-clinical and commercial stage
• Emergence of downstream disposables
• SUT aiding continuous bioprocessing

PART 13: Vendor landscape

• Competitive scenario

PART 14: Key vendor analysis

• Danaher
• GE Healthcare
• Merck
• Sartorius
• Thermo Fisher Scientific
• Other prominent vendors

PART 15: Appendix

• List of abbreviations